MKI67 and neoplasm: In addition, clioquinol, MK-2206, and their combination markedly decreased the percentage of Ki67-positive proliferating tumor cells (Fig. 7e, f) without affecting the fraction of cleaved caspase-3-positive apoptotic tumor cells (Fig. 7g, h).